EClinicalMedicine (May 2021)

An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C

  • Amaro Nunes Duarte-Neto,
  • Elia Garcia Caldini,
  • Michele Soares Gomes-Gouvêa,
  • Cristina Takami Kanamura,
  • Renata Aparecida de Almeida Monteiro,
  • Juliana Ferreira Ferranti,
  • Andrea Maria Cordeiro Ventura,
  • Fabiane Aliotti Regalio,
  • Daniela Matos Fiorenzano,
  • Maria Augusta Bento Cicaroni Gibelli,
  • Werther Brunow de Carvalho,
  • Gabriela Nunes Leal,
  • João Renato Rebello Pinho,
  • Artur Figueiredo Delgado,
  • Magda Carneiro-Sampaio,
  • Thais Mauad,
  • Luiz Fernando Ferraz da Silva,
  • Paulo Hilario Nascimento Saldiva,
  • Marisa Dolhnikoff

Journal volume & issue
Vol. 35
p. 100850

Abstract

Read online

Background: COVID-19 in children is usually mild or asymptomatic, but severe and fatal paediatric cases have been described. The pathology of COVID-19 in children is not known; the proposed pathogenesis for severe cases includes immune-mediated mechanisms or the direct effect of SARS-CoV-2 on tissues. We describe the autopsy findings in five cases of paediatric COVID-19 and provide mechanistic insight into the mechanisms involved in the pathogenesis of the disease. Methods: Children and adolescents who died with COVID-19 between March 18 and August 15, 2020 were autopsied with a minimally invasive method. Tissue samples from all vital organs were analysed by histology, electron microscopy (EM), reverse-transcription polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC). Findings: Five patients were included, one male and four female, aged 7 months to 15 years. Two patients had severe diseases before SARS-CoV-2 infection: adrenal carcinoma and Edwards syndrome. Three patients were previously healthy and had multisystem inflammatory syndrome in children (MIS-C) with distinct clinical presentations: myocarditis, colitis, and acute encephalopathy with status epilepticus. Autopsy findings varied amongst patients and included mild to severe COVID-19 pneumonia, pulmonary microthrombosis, cerebral oedema with reactive gliosis, myocarditis, intestinal inflammation, and haemophagocytosis. SARS-CoV-2 was detected in all patients in lungs, heart and kidneys by at least one method (RT-PCR, IHC or EM), and in endothelial cells from heart and brain in two patients with MIS-C (IHC). In addition, we show for the first time the presence of SARS-CoV-2 in the brain tissue of a child with MIS-C with acute encephalopathy, and in the intestinal tissue of a child with acute colitis. Interpretation: SARS-CoV-2 can infect several cell and tissue types in paediatric patients, and the target organ for the clinical manifestation varies amongst individuals. Two major patterns of severe COVID-19 were observed: a primarily pulmonary disease, with severe acute respiratory disease and diffuse alveolar damage, or a multisystem inflammatory syndrome with the involvement of several organs. The presence of SARS-CoV-2 in several organs, associated with cellular ultrastructural changes, reinforces the hypothesis that a direct effect of SARS-CoV-2 on tissues is involved in the pathogenesis of MIS-C. Funding: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Bill and Melinda Gates Foundation.

Keywords